Sanofi, Teva collab to deliver inflammatory bowel disease treatment
Sanofi SA and Teva Pharmaceuticals, a US subsidiary of Teva Pharmaceutical Industries Ltd, on Wednesday announce collaboration to co-develop and co-commercialize asset TEV’574.
Sanofi is a...
Wed, 04/10/2023 - 09:08